Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: The Effect of Technological Based Rehabilitation Practices After Breast Cancer Surgery [NA]
A completed clinical trial evaluating technological-based rehabilitation after breast cancer surgery has finished.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer [NA]
A completed clinical trial evaluated acupressure for aromatase inhibitor–associated musculoskeletal symptoms in postmenopausal breast cancer…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer [Phase 2]
A Phase 2 exploratory trial evaluating individualized neoadjuvant treatment regimens for early HR+/HER2+ breast cancer, currently not yet re…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors [NA]
This clinical trial is evaluating metabolic responses to broccoli microgreens in obese breast cancer survivors and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART
This clinical trial update describes the BRAVE-HEART study, which uses an Active Breathing Coordinator during breast cancer radiotherapy to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing stereotactic radiosurgery with olaparib followed by durvalumab and physician's choice systemic therapy…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study
The IMAGINE study is exploring whether MRI background parenchymal enhancement is a risk factor for breast cancer, and the trial is currently…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Endoxifen in Adults With Hormone Receptor Positive Solid Tumors [Phase 1]
Phase 1 clinical trial update of endoxifen in adults with hormone receptor-positive solid tumors; the study is reported as completed.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: ExBRAC- Expressive Writing in Breast Cancer [NA]
This document provides an update on the ExBRAC trial evaluating expressive writing in individuals with breast cancer, with the study listed …
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease [Phase 2]
Phase 2 trial comparing pembrolizumab plus carboplatin versus carboplatin alone in breast cancer patients with chest wall involvement has co…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Intraoperative Gamma Camera for Breast Cancer Surgery [Phase 3]
This Phase 3 trial evaluating an intraoperative gamma camera for breast cancer surgery has completed. The study investigated breast cancer a…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial of patritumab deruxtecan (U3-1402) in metastatic breast cancer and locally advanced breast cancer has completed. The update …
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases
This clinical trial update describes a study investigating whether patient-derived organoids from breast cancer metastases can predict treat…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy [Phase 2]
This update describes a Phase 2 clinical trial evaluating the safety of neoadjuvant palbociclib in combination with endocrine therapy for br…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating ribociclib with adjuvant endocrine therapy for ER-positive breast cancer is active but not recruiting at…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
A recruiting clinical trial investigating whether selenoproteins can serve as prognostic biomarkers and therapeutic targets in breast cancer…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Prospective Study on ICG Lymphoscintigraphy Changes Before and After Radiotherapy in Breast Cancer Patients
A prospective study is evaluating changes in indocyanine green (ICG) lymphoscintigraphy in breast cancer patients before and after radiother…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) [Phase 2]
This document describes a Phase 2, single-arm, open-label pilot trial of Zanidatamab (ZW25) for early-stage HER2-positive breast cancer, whi…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope [NA]
This trial update describes using methylene blue with a radiopharmaceutical isotope to identify sentinel lymph nodes in breast cancer.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study [NA]
Prospective, open-label, single-arm exploratory trial investigating the safety and feasibility of irreversible electroporation (IRE) for ear…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM) [NA]
This clinical trial update describes a prospective pilot study of robot-assisted nipple-sparing mastectomy (RNSM) for breast cancer and duct…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression [Phase 2]
Phase 2 clinical trial update on [99mTc]Tc-DB8 imaging agent in primary breast cancer assessing ER-positive and ER-negative tumors; current …
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: REJOIN Trial for Older Breast Cancer Survivors [NA]
The REJOIN trial evaluating treatments for older breast cancer survivors has completed; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences [Phase 1]
A Phase 1 trial evaluating the combination of hyperthermia and Olaparib for breast cancer patients with chest wall recurrences has been term…